Fluoroquinolone use is a risk factor for methicillin-resistant staphylococcus aureus acquisition in long-term care facilities: A nested case-case-control study

Clinical Infectious Diseases

Volumn 59, Issue 2, 2014, Pages 206-215

  Couderc, Clotilde ^a,b,c   Jolivet, Sarah ^a,b,c   Thiébaut, Anne C M ^a,b,c   Ligier, Caroline ^a,b,c   Remy, Laetitia ^d   Alvarez, Anne Sophie ^d   Lawrence, Christine ^d   Salomon, Jérôme ^e   Herrmann, Jean Louis ^d,f   Guillemot, Didier ^a,b,c   Bernede Bauduin C ^g   Bertucci, I ^g   Dupont, C ^g   Le Minor, O ^g   Petit, A ^g   Sorel, T ^g  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c University Versailles Saint Quentin UVSQ   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

^e University of Paris Cité   (France)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^g NONE

Author keywords

acquisition

Indexed keywords

QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ADOLESCENT; AGED; DRUG UTILIZATION; FRANCE; HETEROZYGOTE; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CASE-CONTROL STUDIES; COHORT STUDIES; DRUG UTILIZATION; FEMALE; FLUOROQUINOLONES; FRANCE; HUMANS; INCIDENCE; LONG-TERM CARE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NASAL MUCOSA; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84904026100     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu236     Document Type: Article

References (39)

1. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 2001; 344:11-6. (Pubitemid 32064839)
2. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005; 5:751-62. (Pubitemid 41688980)
3. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322:505-9. (Pubitemid 20067827)
4. Nguyen MH, Kauffman CA, Goodman RP, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999; 130:221-5. (Pubitemid 29078783)
5. Desai D, Desai N, Nightingale P, Elliott T, Neuberger J. Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl 2003; 9:754-9. (Pubitemid 36874466)
6. Balm MN, Lover AA, Salmon S, Tambyah PA, Fisher DA. Progression from new methicillin-resistant Staphylococcus aureus colonisation to infection: An observational study in a hospital cohort. BMC Infect Dis. 2013; 13:491.
7. Jevons MP. "Celbenin"-resistant staphylococci. Br Med J 1961; 1:972-3.
8. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368:874-85. (Pubitemid 44308640)
9. Pittet D,Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155:1177-84.
10. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-74. (Pubitemid 40445022)
11. Kock R, Becker K, Cookson B, et al. Methicillin-resistant Staphylococcus aureus (MRSA): Burden of disease and control challenges in Europe. Euro Surveill 2010; 15:19688.
12. Alexander EL, Morgan DJ, Kesh S, et al. Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital. Diagn Microbiol Infect Dis. 2011; 70:37-44.
13. Asensio A, Guerrero A, Quereda C, Lizan M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: Associated factors and eradication. Infect Control Hosp Epidemiol 1996; 17:20-8. (Pubitemid 126482558)
14. Bassetti M, Trecarichi EM, Mesini A, et al. Risk factors and mortality of healthcare-Associated and community-Acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2012; 18:862-9.
15. Bilavsky E, Lerman Y, Rabinovich A, et al. Carriage of methicillinresistant Staphylococcus aureus on admission to European rehabilitation centres-A prospective study. Clin Microbiol Infect 2012; 18: E164-9.
16. Pittet D, Allegranzi B, Sax H, et al. Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis. 2006; 6:641-52. (Pubitemid 44427733)
17. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2000; 31:1380-5.
18. Dziekan G, Hahn A, Thune K, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: Investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000; 46:263-70. (Pubitemid 32059793)
19. Salangsang JA, Harrison LH, Brooks MM, Shutt KA, Saul MI, Muto CA. Patient-Associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Infect Control Hosp Epidemiol 2010; 31:1139-47.
20. Lee BY, Bartsch SM, Wong KF, et al. The importance of nursing homes in the spread of methicillin-resistant Staphylococcus aureus (MRSA) among hospitals. Med Care 2013; 51:205-15.
21. Kaye KS, Harris AD, Samore M, Carmeli Y. The case-case-control study design: Addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 2005; 26:346-51. (Pubitemid 40545579)
22. Blot S, De Bacquer D, Hoste E, et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 2005; 26:352-6. (Pubitemid 40545580)
23. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review. Clin Infect Dis. 2001; 32:1055-61. (Pubitemid 32299641)
24. Merrer J, Santoli F, Appere de Vecchi C, Tran B, De Jonghe B, Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000; 21:718-23.
25. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49: 999-1005. (Pubitemid 34692894)
26. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003; 9:1415-22. (Pubitemid 37356215)
27. Ernst EJ, Raley G, Herwaldt LA, Diekema DJ. Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:634-7. (Pubitemid 41073404)
28. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? a systematic review and meta-Analysis. J Antimicrob Chemother 2008; 61:26-38.
29. Knight GM, Budd EL, Whitney L, et al. Shift in dominant hospital-Associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother 2012; 67:2514-22.
30. Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis. 1997; 24(Suppl 1): S67-73.
31. Bisognano C, Vaudaux PE, Lew DP, Ng EY, Hooper DC. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997; 41:906-13. (Pubitemid 27194158)
32. Bisognano C, Vaudaux P, Rohner P, Lew DP, Hooper DC. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 2000; 44:1428-37. (Pubitemid 30340774)
33. Venezia RA, Domaracki BE, Evans AM, Preston KE, Graffunder EM. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother 2001; 48:375-81. (Pubitemid 32898808)
34. O'Sullivan NP, Keane CT. Risk factors for colonization with methicillinresistant Staphylococcus aureus among nursing home residents. J Hosp Infect 2000; 45:206-10.
35. Kupfer M, Jatzwauk L, Monecke S, Mobius J, Weusten A. MRSA in a large German University Hospital: Male gender is a significant risk factor forMRSA acquisition. GMS Krankenhhyg Interdiszip 2010; 5:pii:Doc 11.
36. den Heijer CD, van Bijnen EM, Paget WJ, et al. Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: A cross-sectional study. Lancet Infect Dis. 2013; 13:409-15.
37. Dauwalder O, Lina G, Durand G, et al. Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007. J Clin Microbiol 2008; 46:3454-8.
38. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B; Multicenter Study Group. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: Results of a multicenter study. Arch Intern Med 2003; 163:181-8. (Pubitemid 36124003)
39. Nicolle LE, Bentley DW, Garibaldi R, Neuhaus EG, Smith PW. Antimicrobial use in long-term-care facilities. SHEA Long-Term-Care Committee. Infect Control Hosp Epidemiol 2000; 21:537-45. (Pubitemid 30647162)